Breaking News Instant updates and real-time market news.

ALXN

Alexion

$109.55 /

+ (+0.00%)

09:43
01/13/20
01/13
09:43
01/13/20
09:43

Alexion sees 20% revenue growth in 2019 as compared to 2018

Alexion Pharmaceuticals disclosed earlier in a regulatory filing that it will participate in the 38th Annual J.P. Morgan Healthcare Conference in San Francisco, California on January 13-16. Alexion CEO Ludwig Hantson will make a presentation on Tuesday, January 14th, at 10:30 a.m. ET during which the company expects that Mr. Hantson will discuss two new additional development programs; that as of December 31, 2019, SOLIRIS NMOSD and gMG patients in the United States totaled 1,885; that Alexion achieved greater than 20% revenue growth in 2019 as compared to 2018. This amount is a preliminary estimate and is subject to completion of the audit of the income statement for the fiscal year ended December 31, 2019. The company also expects him to provide updated ULTOMIRIS PNH patient conversion numbers as of January 10, 2020; discuss the timing of anticipated future product launches and clinical trials; discuss anticipated neurology patients on Alexion products by 2025; discuss information regarding the expected clinical trial of ULTOMIRIS for ALS; talk about revenue attributable to sales of metabolic products in 2019 and to discuss that the deadline established in its by-laws for shareholders to nominate directors for consideration at the 2020 annual meeting has passed and that the company did not receive any director nominations from shareholders. The FY19 consensus for revenue is $4.91B.

  • 13

    Jan

  • 13

    Jan

  • 27

    Jan

ALXN Alexion
$109.55 /

+ (+0.00%)

01/07/20 WBLR
Alexion's complement franchise durability undervalued, says William Blair
01/07/20 PIPR
Piper 'breathing a sigh of relief' for Alexion, thinks Apellis 'falls short'
01/07/20 SBSH
Apellis price target raised to $80 from $37 at Citi
01/07/20 JPMS
Alexion competitor data 'good,' but impact likely incremental, says JPMorgan

TODAY'S FREE FLY STORIES

Periodicals
Potential Dean Foods deal probed by Justice Department, WSJ reports » 12:58
01/27/20
01/27
12:58
01/27/20
12:58
DFODQ

Dean Foods

$0.00 /

+ (+0.00%)

, DF

Dean Foods

$0.00 /

+ (+0.00%)

The Justice Department is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
Treasury 5-year auction preview: » 12:55
01/27/20
01/27
12:55
01/27/20
12:55

Treasury 5-year auction…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
U.S. Senate Impeachment Trial: Day 7 » 12:55
01/27/20
01/27
12:55
01/27/20
12:55

The Senate Impeachment…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Pursuit of coronavirus treatment has shares of Vir Biotechnology soaring » 12:51
01/27/20
01/27
12:51
01/27/20
12:51
VIR

Vir Biotechnology

$24.28 /

+4.49 (+22.69%)

Shares of Vir…

Shares of Vir Biotechnology are soaring amid reports that the coronavirus continues to spread. The company last week said it is "working to rapidly determine whether its previously identified anti-coronavirus monoclonal antibodies bind and neutralize 2019-nCoV, also referred to as 'Wuhan coronavirus.'" Skip Virgin, Chief Scientific Officer of Vir, added, "We have a library of multiple fully-human mAbs that bind and neutralize coronaviruses such as SARS and MERS. These mAbs were discovered using our antibody platform that identifies mAbs from survivors of an infection. Some of these mAbs are able to neutralize zoonotic coronaviruses, and we believe may have the potential to treat and prevent Wuhan coronavirus. We are also exploring the isolation of new mAbs specific for this virus." In addition to Vir's mAb efforts, its scientists are planning to apply whole genome CRISPR-based screening capabilities to identify the host receptor that allows Wuhan coronavirus infection. "This may allow additional approaches to address this rapidly emerging public health concern," the company said in last week's statement. George Scangos, CEO of Vir cautioned, "We don't know yet if these efforts will be successful, but we are working aggressively to find out." Shares of Vir Biotechnology are up 26%, or $5.20, to $25.39 in afternoon trading.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Options
SmileDirectClub call volume above normal and directionally bullish » 12:45
01/27/20
01/27
12:45
01/27/20
12:45
SDC

SmileDirectClub

$13.51 /

+0.46 (+3.52%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Credit Suisse's Thiam denies claim he sought out damaging information, WSJ says » 12:36
01/27/20
01/27
12:36
01/27/20
12:36
CS

Credit Suisse

$13.11 /

-0.355 (-2.64%)

Credit Suisse CEO Tidjane…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Options
Nike call volume above normal and directionally bullish » 12:25
01/27/20
01/27
12:25
01/27/20
12:25
NKE

Nike

$100.21 /

-1.82 (-1.78%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

On The Fly
Fly Intel: Wall Street's top stories at midday » 12:23
01/27/20
01/27
12:23
01/27/20
12:23
WYNN

Wynn Resorts

$125.24 /

-9.53 (-7.07%)

, EL

Estee Lauder

$196.28 /

-9.04 (-4.40%)

, LVS

Las Vegas Sands

$63.80 /

-4.04 (-5.96%)

, MGM

MGM Resorts

$30.59 /

-0.98 (-3.10%)

, MLCO

Melco Resorts & Entertainment

$20.34 /

-0.91 (-4.28%)

, VIVO

Meridian Bioscience

$11.43 /

+1.91 (+20.06%)

, ACHN

Achillion

$6.95 /

+0.81 (+13.20%)

, ALXN

Alexion

$104.81 /

-0.43 (-0.41%)

, SEDG

SolarEdge

$101.40 /

-8.73 (-7.93%)

, SALT

Scorpio Bulkers

$4.07 /

-0.45 (-9.96%)

, UAL

United Airlines

$78.21 /

-3.71 (-4.53%)

, DAL

Delta Air Lines

$56.78 /

-2.03 (-3.45%)

, AAL

American Airlines

$26.18 /

-1.48 (-5.35%)

, RCL

Royal Caribbean

$118.48 /

-8.01 (-6.33%)

, CCL

Carnival

$45.82 /

-1.73 (-3.64%)

, CUK

Carnival plc

$43.17 /

-1.68 (-3.75%)

, NCLH

Norwegian Cruise Line

$54.04 /

-1.81 (-3.24%)

, MCD

McDonald's

$210.26 /

-0.95 (-0.45%)

, YUMC

Yum China

$42.40 /

-1.89 (-4.27%)

, SBUX

Starbucks

$88.98 /

-3.05 (-3.31%)

, DPZ

Domino's Pizza

$285.00 /

-0.41 (-0.14%)

, NKE

Nike

$100.20 /

-1.83 (-1.79%)

, TPR

Tapestry

$26.74 /

-0.545 (-2.00%)

Stocks are pulling back…

Open Full Text

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
PhaseBio could see increase to PB2452 addressable market, says William Blair » 12:20
01/27/20
01/27
12:20
01/27/20
12:20
PHAS

PhaseBio

$5.21 /

-0.09 (-1.70%)

, AZN

AstraZeneca

$48.83 /

-0.45 (-0.91%)

William Blair analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Technical Analysis
NASDAQ market internals summary » 12:17
01/27/20
01/27
12:17
01/27/20
12:17
$NSD

NASDAQ Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Recommendations
Liquidia NDA acceptance reduces regulatory risk, says Wedbush » 12:16
01/27/20
01/27
12:16
01/27/20
12:16
LQDA

Liquidia Technologies

$6.00 /

-0.5 (-7.69%)

Wedbush analyst Liana…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Technical Analysis
NYSE market internals summary » 12:16
01/27/20
01/27
12:16
01/27/20
12:16
$NYE

NYSE Market Internals

$0.00 /

+ (+0.00%)

Volume is average for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Options
Cabot Oil & Gas put volume heavy and directionally bearish » 12:15
01/27/20
01/27
12:15
01/27/20
12:15
COG

Cabot Oil & Gas

$14.32 /

-0.32 (-2.19%)

Bearish flow noted in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Over 350 workers call out Amazon's climate plan on Medium, Earther says » 12:14
01/27/20
01/27
12:14
01/27/20
12:14
AMZN

Amazon.com

$1,833.80 /

-28.29 (-1.52%)

While Amazon told workers…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Motorola possibly working on new pen-equipped mobile phone, Engadget says » 12:09
01/27/20
01/27
12:09
01/27/20
12:09
MSI

Motorola Solutions

$176.83 /

-2.84 (-1.58%)

, SSNLF

Samsung

$0.00 /

+ (+0.00%)

Motorola (MSI) may be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Apple files patent for AIO computer with curved glass sheet, Patently Apple says » 12:06
01/27/20
01/27
12:06
01/27/20
12:06
AAPL

Apple

$309.34 /

-8.93 (-2.81%)

The U.S. Patent and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
Treasury's $39 B 6-month bill auction was poorly subscribed » 12:05
01/27/20
01/27
12:05
01/27/20
12:05

Treasury's $39 B…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
USA Technologies investor sends open letter to board » 12:03
01/27/20
01/27
12:03
01/27/20
12:03
USAT

USA Technologies

$0.00 /

+ (+0.00%)

22NW, acting…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
NIO Inc. falls -9.6% » 12:00
01/27/20
01/27
12:00
01/27/20
12:00
NIO

NIO Inc.

$4.22 /

-0.44 (-9.44%)

NIO Inc. is down -9.6%,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Laix falls -9.6% » 12:00
01/27/20
01/27
12:00
01/27/20
12:00
LAIX

Laix

$4.89 /

-0.47 (-8.77%)

Laix is down -9.6%, or…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Scorpio Bulkers falls -11.3% » 12:00
01/27/20
01/27
12:00
01/27/20
12:00
SALT

Scorpio Bulkers

$4.00 /

-0.52 (-11.50%)

Scorpio Bulkers is down…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Britannia Bulk rises 9.7% » 12:00
01/27/20
01/27
12:00
01/27/20
12:00
DWT

Britannia Bulk

$5.33 /

+0.51 (+10.58%)

Britannia Bulk is up…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
ProShares Trust Ultra VIX Short Term Futures ETF rises 11.3% » 12:00
01/27/20
01/27
12:00
01/27/20
12:00
UVXY

ProShares Trust Ultra VIX Short Term Futures ETF

$13.07 /

+1.36 (+11.61%)

ProShares Trust Ultra VIX…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Ovintiv rises 375.9% » 12:00
01/27/20
01/27
12:00
01/27/20
12:00
OVV

Ovintiv

$18.03 /

+14.24 (+375.73%)

Ovintiv is up 375.9%, or…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
Options
Size call call spread buyer in VXX positions for higher near-term volatility » 12:00
01/27/20
01/27
12:00
01/27/20
12:00
VXX

iPath S&P 500 VIX Short-Term Futures

$15.32 /

+1.08 (+7.58%)

Size call call spread…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.